Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yung Lyou
Observed names:
Lyou, Yung,
Y. Lyou
Institutions:
City Of Hope National Medical Center,
St. Jude Medical Center,
City of Hope
Observed institutions:
City Of Hope National Medical Center,
State University of New York,
SUNY Upstate Medical University,
University of California, Irvine,
St. Jude Medical Center,
University of California, Irvine Medical Center,
City of Hope
show all 7
ORCID:
0000-0003-4201-4040
Observed ORCID:
0000-0003-4201-4040
OpenAlex ID:
A5028660468
Global Reorganization of Replication Domains During Embryonic Stem Cell Differentiation
2008
·
Ichiro Hiratani
, Tyrone Ryba
, et al.
·
PLoS Biology
·
617
PDF
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial
2022
·
Nazli Dizman
, Luis Meza
, et al.
·
Nature Medicine
·
556
PDF
Machine Learning–Based Interpretation and Visualization of Nonlinear Interactions in Prostate Cancer Survival
2020
·
Richard Li
, Ashwin Shinde
, et al.
·
JCO Clinical Cancer Informatics
·
123
Lactate/pyruvate transporter MCT-1 is a direct Wnt target that confers sensitivity to 3-bromopyruvate in colon cancer
2016
·
Stephanie Sprowl-Tanio
, Amber N. Habowski
, et al.
·
Cancer & Metabolism
·
109
PDF
Generation of Functional Eyes from Pluripotent Cells
2009
·
Andrea S. Viczian
, Eduardo C. Solessio
, et al.
·
PLoS Biology
·
74
PDF
Correlates of clinical benefit from immunotherapy and targeted therapy in metastatic renal cell carcinoma: comprehensive genomic and transcriptomic analysis
2020
·
Nazli Dizman
, Yung Lyou
, et al.
·
Journal for ImmunoTherapy of Cancer
·
68
Inhibition of nuclear Wnt signalling: challenges of an elusive target for cancer therapy
2017
·
Yung Lyou
, Amber N Habowski
, et al.
·
British Journal of Pharmacology
·
58
Effect of Cisplatin and Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma: A Phase 2 Randomized Clinical Trial
2021
·
Sumanta K. Pal
, Paul H. Frankel
, et al.
·
JAMA Oncology
·
49
PDF
Wnt/β-Catenin Signaling and Immunotherapy Resistance: Lessons for the Treatment of Urothelial Carcinoma
2021
·
Alexander Chehrazi-Raffle
, Tanya B. Dorff
, et al.
·
Cancers
·
46
PDF
Disruption of β-Catenin–Dependent Wnt Signaling in Colon Cancer Cells Remodels the Microenvironment to Promote Tumor Invasion
2021
·
George T. Chen
, Delia F. Tifrea
, et al.
·
Molecular Cancer Research
·
33
PDF
Hyperphosphatemia Secondary to the Selective Fibroblast Growth Factor Receptor 1–3 Inhibitor Infigratinib (BGJ398) Is Associated with Antitumor Efficacy in Fibroblast Growth Factor Receptor 3–altered Advanced/Metastatic Urothelial Carcinoma
2020
·
Yung Lyou
, Petros Grivas
, et al.
·
European Urology
·
31
Advances in Immunotherapy and the TGF-β Resistance Pathway in Metastatic Bladder Cancer
2021
·
David J. Benjamin
, Yung Lyou
·
Cancers
·
29
PDF
Maturin is a novel protein required for differentiation during primary neurogenesis
2013
·
Reyna I. Martinez-De Luna
, Ray Yueh Ku
, et al.
·
Developmental Biology
·
28
PDF
Infigratinib in Early-Line and Salvage Therapy for FGFR3-Altered Metastatic Urothelial Carcinoma
2021
·
Yung Lyou
, Jonathan E. Rosenberg
, et al.
·
Clinical Genitourinary Cancer
·
22
A Practical Guide to Relugolix: Early Experience With Oral Androgen Deprivation Therapy
2023
·
Saro Kasparian
, Oren Wei
, et al.
·
The Oncologist
·
19
PDF
First results of a randomized phase IB study comparing nivolumab/ipilimumab with or without CBM-588 in patients with metastatic renal cell carcinoma.
2021
·
Luis A Meza
, Nazli Dizman
, et al.
·
Journal of Clinical Oncology
·
16
Radiation-Associated Angiosarcoma of the Breast: A Case Report and Literature Review
2018
·
Yung Lyou
, Emily Barber
, et al.
·
Case Reports in Oncology
·
13
Managing Bladder Cancer Care during the COVID-19 Pandemic Using a Team-Based Approach
2020
·
Tina Wang
, Sariah Liu
, et al.
·
Journal of Clinical Medicine
·
12
PDF
Genomic and Transcriptomic Predictors of Response from Stereotactic Body Radiation Therapy in Patients with Oligoprogressive Renal Cell Carcinoma
2023
·
Zeynep B. Zengin
, Ameish Govindarajan
, et al.
·
European Urology Oncology
·
10
Pancytopenia in a patient with cystinosis secondary to myelosuppression from cystine crystal deposition: a case report
2015
·
Yung Lyou
, Xiaohui Zhao
, et al.
·
Journal of Medical Case Reports
·
10
PDF
Long-Term Outcomes of Patients on a Phase II Prospective Trial of Oligometastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation and External Beam Radiation
2022
·
Claire Hao
, Colton Ladbury
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
9
Hormonal manipulation in androgen signaling: a narrative review on using novel androgen therapy agents to optimize clinical outcomes and minimize side effects for prostate cancer patients
2021
·
Yung Lyou
, Tanya B. Dorff
·
Translational Andrology and Urology
·
8
Reassessing the role of chemoimmunotherapy in chronic lymphocytic leukemia
2019
·
Yasir Khan
, Yung Lyou
, et al.
·
Expert Review of Hematology
·
7
Infigratinib and treatment response in advanced/unresectable or metastatic urothelial carcinoma in first-line and later-line treatment settings.
2020
·
Yung Lyou
, Petros Grivas
, et al.
·
Journal of Clinical Oncology
·
6
Chimeric Antigen Receptor (CAR) T-cell Treatment in Renal Cell Carcinoma: Current Clinical Trials and Future Directions
2022
·
Yung Lyou
, Tanya B. Dorff
·
Kidney Cancer
·
5
PDF
Show more works
View as search
Works count:
66
Citation count:
1,995
H-index:
16
I10-index:
20
Year
Topic
Type